Ratings by Jefferies (Kambiz Yazdi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/19/2026 | EyePoint Inc. | EYPT | Downgrade | Hold (Buy) |
2.99 (0.40) |
-86.62% | Details | |
| 10/8/2026 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2026 | EyePoint Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Avalo Therapeutics Inc. | AVTX | New Coverage | Buy (N/A) |
7.66 (6.93) |
-9.53% | Details | |
| 3/11/2025 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | New Coverage | Buy (N/A) |
9.30 (0.40) |
-95.7% | Details | |
| 8/28/2024 | Arcutis Biotherapeutics Inc. | ARQT | New Coverage | Buy (N/A) |
10.58 (31.20) |
194.9% | Details | |
| 8/19/2024 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2024 | PMV Pharmaceuticals Inc. | PMVP | New Coverage | Buy (N/A) |
1.51 (1.27) |
-15.89% | Details | |
| 3/26/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Werewolf Therapeutics Inc. | HOWL | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2024 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Werewolf Therapeutics Inc. | HOWL | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Paratek Pharmaceuticals | PRTK | Downgrade | Hold (Buy) |
1.96 (2.23) |
13.78% | Details | |
| 6/6/2023 | Werewolf Therapeutics Inc. | HOWL | New Coverage | Buy (N/A) |
3.36 (1.21) |
-63.99% | Details | |
| 6/2/2023 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
0.86 (252.96) |
29313.95% | Details | |
| 5/31/2023 | Carisma Therapeutics Inc | CARM | New Coverage | Buy (N/A) |
5.18 (0.15) |
-97.1% | Details | |
| 5/2/2023 | Paratek Pharmaceuticals | PRTK | New Coverage | Buy (N/A) |
1.58 (2.23) |
41.14% | Details |
